MOBX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Mobix Labs Inc · Technology · Semiconductors

Open interactive chart View report data
Latest close 1.68 USD
-7.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -38.8% below the Trend Line and sits at 2.9% of its 52-week range. The latest completed week returned -7.2%, after a -18.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 10d.

Setup score 16 out of 100
Latest Close 1.68 USD 31 Jul 2026
1W Return -7.2% latest completed week
4W Return -18.8% short-term follow-through
12W Return -16.0% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.2% Latest completed week; four-week move -18.8%. Indicator stack 7/55 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 34.43% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 63 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -38.8% below the Trend Line and sits at 2.9% of its 52-week range. The latest completed week returned -7.2%, after a -18.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.11

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -18.8% over four weeks, -16.0% over 12 weeks, and -79.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-7.2%
4W-18.8%
12W-16.0%
26W-15.5%
52W-79.5%
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.08Latest activity-pressure read.
Pressure change86.7%Four-week change in activity pressure.
Leadership-68.20Latest relative-leadership reading.
RS change-2.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength51/100Blend of value, momentum, and quality. Underlying universe rank 50; rank 1 is best.
Value50/100Relative valuation strength. Underlying universe rank 51; rank 1 is best.
Quality48/100Profitability and accounting quality. Underlying universe rank 53; rank 1 is best.
Momentum50/100Medium-term price momentum. Underlying universe rank 51; rank 1 is best.
Growth50/100Revenue and earnings growth. Underlying universe rank 51; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
3.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-55.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
43.3%
Gross profit retained from each unit of revenue.
Operating margin
-397.4%
Operating profit retained from revenue.
Free-cash-flow margin
-248.6%
Free cash flow generated from revenue.
Return on invested capital
-163.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-33.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-13.2%
Net share repurchases relative to market value.
Shareholder yield
-13.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 63 relevant articles.

12 positive · 44 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-88.3%Distance below the 52-week high.
13-week volatility8.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+530.3%Week of 6 Mar.
Worst week-39.4%Week of 13 Mar.
Latest week-7.2%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains2
Flat weeks0
Modest losses2
Sharp losses15
Recent vol8.2%13-week weekly-return volatility.
Base vol74.9%52-week weekly-return volatility.
Up/down split14/38Count of positive and negative weeks in the 52-week window.
Average skew49.7% / -11.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis10/100

Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 34.43%

Next-week expectancy is negative with a 34.43% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors49/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 88 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 63 relevant articles.

Mobix Labs Company Profile & Introduction Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.68 USD-7.2%2.74 USD11.23 USD-0.08-68.204.5MOff
24 Jul 20261.81 USD-8.1%2.78 USD11.30 USD-0.15-66.5823.4MOff
17 Jul 20261.97 USD3.1%2.84 USD11.37 USD-0.30-65.581.6MOff
10 Jul 20261.91 USD-7.7%2.90 USD11.45 USD-0.48-68.921.5MOff
3 Jul 20262.07 USD2.0%3.01 USD11.52 USD-0.63-66.641.5MOff
26 Jun 20262.03 USD-3.3%3.12 USD11.59 USD-0.62-67.772.8MOff
19 Jun 20262.10 USD6.1%3.21 USD11.66 USD-0.52-68.903.1MOff
12 Jun 20261.98 USD-8.3%3.29 USD11.73 USD-0.39-70.565.7MOff
5 Jun 20262.16 USD-10.0%3.42 USD11.81 USD-0.17-67.8251.2MOff
29 May 20262.40 USD12.1%3.56 USD11.89 USD-0.11-66.545.7MOff
22 May 20262.14 USD-4.9%3.71 USD11.96 USD-0.05-69.859.7MOff
15 May 20262.25 USD12.5%3.91 USD12.04 USD0.04-68.58172.6MOff
8 May 20262.00 USD-14.2%4.12 USD12.12 USD0.10-72.792.2MOff
1 May 20262.33 USD-20.2%4.33 USD12.20 USD0.17-67.272.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.